Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

SMC Update - August 2012

The Scottish Medicines Consortium (SMC) has issued its monthly advice on newly licensed medicines.

Rifaximin (Xifaxanta®) has been rejected for the treatment of travellers' diarrhoea that is not associated with fever, bloody diarrhoea, 8 or more unformed stools in the previous 24 hours or occult blood or leucocytes in the stool. The manufacturer failed to make a submission.

Action: Clinicians should be aware of the recommendations of the SMC. Routine use of rejected and restricted medicines should be avoided.

Share 'SMC Update - August 2012' on Email Share 'SMC Update - August 2012' on Delicious Share 'SMC Update - August 2012' on Digg Share 'SMC Update - August 2012' on Facebook Share 'SMC Update - August 2012' on reddit Share 'SMC Update - August 2012' on StumbleUpon Share 'SMC Update - August 2012' on Twitter

atomic-wealth

No Comments to “SMC Update - August 2012”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.

atomic-wealth
fond-illness
summer